Last reviewed · How we verify
90Y-DOTA-3-Tyr-Octreotide
At a glance
| Generic name | 90Y-DOTA-3-Tyr-Octreotide |
|---|---|
| Also known as | 90Y DOTATOC |
| Sponsor | David Bushnell |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Nausea
- Vomiting
- Fatigue
- Abdominal pain
- Headache
- Anemia
- Dizziness
- Fever
- Infusion site extravasation
- Lymphocyte count decreased
- Endocrine disorders - Other, specify
- Platelet count decreased
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- 90Y-DOTA-3-Tyr-Octreotide CI brief — competitive landscape report
- 90Y-DOTA-3-Tyr-Octreotide updates RSS · CI watch RSS
- David Bushnell portfolio CI